Initial clinical evaluation of N-trifluoroacetyladriamycin-14-valerate (AD-32), an adriamycin analog

R. H. Blum, M. B. Garnick, M. Israel, G. P. Canellos, I. C. Henderson, E. Frei IIIrd

Research output: Contribution to journalArticlepeer-review

38 Scopus citations

Fingerprint

Dive into the research topics of 'Initial clinical evaluation of N-trifluoroacetyladriamycin-14-valerate (AD-32), an adriamycin analog'. Together they form a unique fingerprint.

Medicine & Life Sciences